Zhang J - Search Results

1

The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells.

Ma Y, Hao X, Zhang S, Zhang J. Ma Y, et al. Among authors: zhang s, zhang j. Breast Cancer Res Treat. 2012 Jun;133(2):473-85. doi: 10.1007/s10549-011-1774-x. Epub 2011 Sep 23. Breast Cancer Res Treat. 2012. PMID: 21947651

2

Effects of the combination of RAD001 and docetaxel on breast cancer stem cells.

Zhang X, Zhang S, Liu Y, Liu J, Ma Y, Zhu Y, Zhang J. Zhang X, et al. Among authors: zhang s, zhang j. Eur J Cancer. 2012 Jul;48(10):1581-92. doi: 10.1016/j.ejca.2012.02.053. Epub 2012 Mar 13. Eur J Cancer. 2012. PMID: 22420943

3

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo.

Zhu Y, Zhang X, Liu Y, Zhang S, Liu J, Ma Y, Zhang J. Zhu Y, et al. Among authors: zhang s, zhang j, zhang x. Tumour Biol. 2012 Oct;33(5):1349-62. doi: 10.1007/s13277-012-0383-6. Epub 2012 Apr 11. Tumour Biol. 2012. PMID: 22492237

4

Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.

Hou G, Zhang S, Zhang X, Wang P, Hao X, Zhang J. Hou G, et al. Among authors: zhang s, zhang j, zhang x. Breast Cancer Res Treat. 2013 Feb;137(3):807-16. doi: 10.1007/s10549-012-2404-y. Epub 2013 Jan 6. Breast Cancer Res Treat. 2013. PMID: 23292119

5

Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study.

Liu Y, Zhang X, Liu J, Hou G, Zhang S, Zhang J. Liu Y, et al. Among authors: zhang s, zhang j, zhang x. Tumour Biol. 2014 Feb;35(2):1275-86. doi: 10.1007/s13277-013-1170-8. Epub 2013 Sep 8. Tumour Biol. 2014. PMID: 24014089

6

GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells.

Lan ZJ, Hu Y, Zhang S, Li X, Zhou H, Ding J, Klinge CM, Radde BN, Cooney AJ, Zhang J, Lei Z. Lan ZJ, et al. Among authors: zhang s, zhang j. Breast Cancer Res Treat. 2016 Jul;158(2):263-76. doi: 10.1007/s10549-016-3880-2. Epub 2016 Jun 29. Breast Cancer Res Treat. 2016. PMID: 27357812

7

HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells.

Bai J, Zhou G, Qiu Y, Hu Y, Liu J, Zhao J, Zhang S, Zhang J. Bai J, et al. Among authors: zhang s, zhang j. Cancer Sci. 2017 Jun;108(6):1177-1184. doi: 10.1111/cas.13238. Epub 2017 May 19. Cancer Sci. 2017. PMID: 28301080 Free PMC article.

8

Breast-conserving therapy versus modified radical mastectomy: socioeconomic status determines who receives what--results from case-control study in Tianjin, China.

Liu JJ, Zhang S, Hao X, Xie J, Zhao J, Wang J, Liu L, Wang PP, Zhang J. Liu JJ, et al. Among authors: zhang s, zhang j. Cancer Epidemiol. 2012 Feb;36(1):89-93. doi: 10.1016/j.canep.2011.04.005. Epub 2011 May 25. Cancer Epidemiol. 2012. PMID: 21613000

9

Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.

Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Liu J, et al. Among authors: zhang s, zhang j. Chin J Cancer Res. 2013 Feb;25(1):46-54. doi: 10.3978/j.issn.1000-9604.2012.11.04. Chin J Cancer Res. 2013. PMID: 23372341 Free PMC article.

10

[Protective effect of dexrazoxane on cardiotoxicity in breast cancer patients who received anthracycline-containing chemotherapy].

Wang P, Zhang S, Zhang XB, Li WJ, Hao XM, Zhang J. Wang P, et al. Among authors: zhang xb, zhang s, zhang j. Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):135-9. doi: 10.3760/cma.j.issn.0253-3766.2013.02.013. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23714670 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179,739 results

Search Page

Filters